Worsening of alcohol abuse disorder in a Spanish population during the first twelve months of the COVID-19 pandemic and associated factors: retrospective, ecological and community study.

Publication date: Jul 12, 2023

To analyse: (1) Changes in clinical parameters and in the use of social healthcare resources by patients with alcohol abuse disorder between the six months prior to the start of the pandemic and the first year of the pandemic. (2) The factors related to a worsening of clinical parameters among patients with alcohol abuse disorder. A retrospective and observational study of a population who have been diagnosed with alcohol abuse disorders according to their primary health care (PHC) electronic medical records was performed. The total sample was made up of 11,384 patients. The variables (sociodemographic variables, chronic comorbidities, analytical parameters related to alcohol abuse disorder, COVID-19 infection, and use of healthcare resources) were collected in three different time periods: (i) six months before the onset of the strict lockdown, (ii) six months following the end of lockdown and (iii) from six to twelve months after the end of lockdown. Paired Student’s T-test and a multivariate logistic regression were performed. Along the first year after the onset of the pandemic, between 44% and 54% of the patients suffered a decline in every clinical parameter. The number of PHC nursing, GP visits and social worker visits reduced significantly. As regards the associated factors related to deterioration of alcohol abuse disorder, being younger than 40 years old, having an income of over 18,000 euros/year and not having visited the social worker were associated with a worsening of the disorder. These results suggest that the impact of COVID-19 on this group has been high, and the social care offered to these patients plays a significant role in minimising the repercussions of the pandemic.

Open Access PDF

Concepts Keywords
Euros Alcohol abuse disorder
Pandemic COVID-19 pandemic
Psychiatry Health care
Spanish Social care


Type Source Name
disease MESH alcohol abuse
disease VO population
disease MESH COVID-19 pandemic
disease MESH infection
disease VO time
pathway REACTOME Reproduction
drug DRUGBANK Coenzyme M
disease MESH morbidity
drug DRUGBANK Ethanol
disease MESH premature death
disease MESH stroke
disease MESH cancers
disease MESH liver cirrhosis
disease MESH mental illnesses
disease MESH insomnia
disease MESH suicide
disease MESH violence
disease MESH unemployment
disease IDO contact tracing
disease VO organization
disease MESH chronic diseases
disease IDO history
drug DRUGBANK Methionine
disease MESH heart failure
disease MESH ischemic heart disease
disease MESH hypertension
disease MESH obesity
disease VO vein
disease MESH cerebrovascular disease
disease MESH chronic bronchitis
disease MESH COPD
disease MESH asthma
pathway KEGG Asthma
disease MESH chronic kidney disease
disease MESH hyperthyroidism
disease MESH hearing loss
disease MESH cataracts
disease MESH glaucoma
disease MESH osteoarthritis
disease MESH osteoporosis
disease MESH back pain
disease MESH nicotine addiction
pathway KEGG Nicotine addiction
disease MESH dementia
disease IDO blood
drug DRUGBANK Creatinine
disease MESH emergency
disease VO frequency
disease MESH comorbidity
disease VO protocol
drug DRUGBANK Iron
drug DRUGBANK Nicotine
pathway KEGG Alcoholism
disease VO age
disease MESH Hypothyroidism
drug DRUGBANK Trestolone
drug DRUGBANK Saquinavir
disease MESH infectious diseases
disease MESH emotional distress
drug DRUGBANK Tretamine
disease VO effective
disease MESH substance abuse
disease MESH lifestyles
disease MESH Alcoholic Liver Disease
pathway KEGG Alcoholic liver disease
drug DRUGBANK Guanosine
drug DRUGBANK Etoperidone
drug DRUGBANK (S)-Des-Me-Ampa
disease MESH complications
disease VO report
disease MESH Schizophrenia
drug DRUGBANK Medical Cannabis

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *